High-resolution analysis by whole-genome sequencing of an international lineage (Sequence Type 111) of pseudomonas aeruginosa associated with metallo-carbapenemases in the United Kingdom

Journal of Clinical Microbiology

Volumn 53, Issue 8, 2015, Pages 2622-2631

  Turton, Jane F ^a   Wright, Laura ^a   Underwood, Anthony ^a   Witney, Adam A ^c   Chan, Yuen Ting ^a   Al Shahib, Ali ^a   Arnold, Catherine ^a   Doumith, Michel ^a   Patel, Bharat ^b   Planche, Timothy D ^c,d   Green, Jonathan ^a   Holliman, Richard ^b,c,d   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Public Health Laboratories Service   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; METALLO BETA LACTAMASE; BACTERIAL PROTEIN; BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; EVOLUTIONARY ADAPTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; INTEGRON; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; VARIABLE NUMBER OF TANDEM REPEAT; BACTERIAL GENOME; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; ENZYMOLOGY; EPIDEMIC; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; BETA-LACTAMASES; CLUSTER ANALYSIS; DISEASE OUTBREAKS; ENVIRONMENTAL MICROBIOLOGY; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; UNITED KINGDOM;

EID: 84938150012     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00505-15     Document Type: Article

References (48)

1. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:736-755. http://dx.doi.org/10.1111/j.1574-6976.2011.00268.x.
2. Mulet X, Cabot G, Ocampo-Sosa AA, Domínguez MA, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI). 2013. Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother 57:5527-5535. http://dx.doi.org/10.1128/AAC.01481-13.
3. Snitkin ES, Zelazny AM, Thomas PJ, Stock F; NISC Comparative Sequencing Program Group, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116.
4. Snyder LA, Loman NJ, Faraj LA, Levi K, Weinstock G, Boswell TC, Pallen MJ, Ala?Aldeen DA. 2013. Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing. Euro Surveill 18(42): piiβ20611. http://www.eurosurveillance.org/ViewArticle.aspx?Arti cleIdß20611.
5. Le VT, Diep BA. 2013. Selected insights from application of wholegenome sequencing for outbreak investigations. Curr Opin Crit Care 19: 432-439. http://dx.doi.org/10.1097/MCC.0b013e3283636b8c.
6. Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN. 2014. Epidemiology and carbapenem resistance mechanisms of carbapenemnon-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother 69: 1804-1814. http://dx.doi.org/10.1093/jac/dku048.
7. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-β-lactamases: a last frontier for-lactams? Lancet Infect Dis 11:381-393. http://dx.doi.org/10.1016/S1473-3099(11)70056-1.
8. Poirel L, Bonnin RA, Nordmann P. 2012. Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods. Infect Genet Evol 12:883-893. http://dx.doi.org/10.1016/j.meegid.2012.02.008.
9. Pasteran F, Faccone D, Gomez S, De Bunder S, Spinelli F, Rapoport M, Petroni A, Galas M, Corso A. 2012. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother 67:1291-1293. http://dx.doi.org/10.1093/jac/dks032.
10. Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. 2015. Dominance of international ?high-risk clones? among metallo-β-lactamase-producing Pseudomonas aeruginosa in the United Kingdom. J Antimicrob Chemother 70:103-110. http://dx.doi.org/10.1093/jac/dku339.
11. Pirnay JP, Bilocq F, Pot B, Cornelis P, Zizi M, Van Eldere J, Deschaght P, Vaneechoutte M, Jennes S, Pitt T, De Vos D. 2009. Pseudomonas aeruginosa population structure revisited. PLoS One 4:e7740. http://dx.doi.org/10.1371/journal.pone.0007740.
12. Edalucci E, Spinelli R, Dolzani L, Riccio ML, Dubois V, Tonin EA, Rossolini GM, Lagatolla C. 2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin Microbiol Infect 14:88-90. http://dx.doi.org/10.1111/j.1469-0691.2007.01874.x.
13. Liakopoulos A, Mavroidi A, Katsifas EA, Theodosiou A, Karagouni AD, Miriagou V, Petinaki E. 2013. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis 13:505. http://dx.doi.org/10.1186/1471-2334-13-505.
14. Koutsogiannou M, Drougka E, Liakopoulos A, Jelastopulu E, Petinaki E, Anastassiou ED, Spiliopoulou I, Christofidou M. 2013. Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital. J Clin Microbiol 51:665-668. http://dx.doi.org/10.1128/JCM.03071-12.
15. Van der Bij AK, Van der Zwan D, Peirano G, Severin JA, Pitout JD, Van Westreenen M, Goessens WH; MBL-PA Surveillance Study Group. 2012. Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin Microbiol Infect 18:E369-E372. http://dx.doi.org/10.1111/j.1469-0691.2012.03969.x.
16. Gilarranz R, Juan C, Castillo-Vera J, Chamizo FJ, Artiles F, Alamo I, Oliver A. 2013. First detection in Europe of the metallo-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa. Clin Microbiol Infect 19:E424-E427. http://dx.doi.org/10.1111/1469-0691.12248.
17. Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, Szabó G, Füzi M. 2008. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res Microbiol 159:162-168. http://dx.doi.org/10.1016/j.resmic.2007.12.008.
18. Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG. 2010. Molecular epidemiology of metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54:346-352. http://dx.doi.org/10.1128/AAC.008 24-09.
19. Sardelic S, Bedenic B, Colinon-Dupuich C, Orhanovic S, Bosnjak Z, Plecko V, Cournoyer B, Rossolini GM. 2012. Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob Agents Chemother 56:2746-2749. http://dx.doi.org/10.1128/AAC.05212-11.
20. Duljasz W, Gniadkowski M, Sitter S, Wojna A, Jebelean C. 2009. First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria. Antimicrob Agents Chemother 53:2221-2222. http://dx.doi.org/10.1128/AAC.01573-08.
21. Hentschke M, Goritzka V, Campos CB, Merkel P, Ilchmann C, Lellek H, Scherpe S, Aepfelbacher M, Rohde H. 2011. Emergence of carbapenemases in Gram-negative bacteria in Hamburg, Germany. Diagn Microbiol Infect Dis 71:312-315. http://dx.doi.org/10.1016/j.diagmicrobio.2011.07.011.
22. Martin K, Baddal B, Mustafa N, Perry C, Underwood A, Constantidou C, Loman N, Kenna DT, Turton JF. 2013. Clusters of genetically similar isolates of Pseudomonas aeruginosa from multiple hospitals in the UK. J Med Microbiol 62:988-1000. http://dx.doi.org/10.1099/jmm.0.054841-0.
23. Witney AA, Gould KA, Pope CF, Bolt F, Stoker NG, Cubbon MD, Bradley CR, Fraise A, Breathnach AS, Butcher PD, Planche TD, Hinds J. 2014. Genome sequencing and characterization of an extensively drugresistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa. Clin Microbiol Infect 20:O609-O618. http://dx.doi.org/10.1111/1469-0691.12528.
24. Cholley P, Thouverez M, Hocquet D, van der Mee-Marquet N, Talon D, Bertrand X. 2011. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol 49:2578-2583. http://dx.doi.org/10.1128/JCM.00102-11.
25. Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A. 2013. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. Microb Drug Resist 19:355-361. http://dx.doi.org/10.1089/mdr.2013.0004.
26. Correa A, Montealegre MC, Mojica MF, Maya JJ, Rojas LJ, De La Cadena EP, Ruiz SJ, Recalde M, Rosso F, Quinn JP, Villegas MV. 2012. First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases. Antimicrob Agents Chemother 56:5422-5423. http://dx.doi.org/10.1128/AAC.00695-12.
27. Turton JF, Turton SE, Yearwood L, Yarde S, Kaufmann ME, Pitt TL. 2010. Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. Clin Microbiol Infect 16:1111-1116. http://dx.doi.org/10.1111/j.1469-0691.2009.03049.x.
28. Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-lactamases. J Antimicrob Chemother 59:321-322.
29. Mushtaq S, Irfan S, Sarma JB, Doumith M, Pike R, Pitout J, Livermore DM, Woodford N. 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 66: 2002-2005. http://dx.doi.org/10.1093/jac/dkr226.
30. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. http://dx.doi.org/10.1093/bioinformatics/btu170.
31. Li H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Cornell University Library. arXiv:1303.3997.
32. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43:491-498. http://dx.doi.org/10.1038/ng.806.
33. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688-2690. http://dx.doi.org/10.1093/bioinformatics/btl446.
34. Miller MA, Pfeiffer W, Schwartz T. 2010. Creating the CIPRES Science Gateway for inference of large phylogenetic trees, p 1-8. In Gateway Computing Environments Workshop (GCE). IEEE, New York, NY.
35. Feliziani S, Marvig RL, Luján AM, Moyano AJ, Di Rienzo JA, Krogh Johansen H, Molin S, Smania AM. 2014. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet 10:e1004651. http://dx.doi.org/10.1371/journal.pgen.1004651.
36. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29:1969-1973. http://dx.doi.org/10.1093/molbev/mss075.
37. Nurk S, Bankevich A, Antipov D, Gurevich AA, Korobeynikov A, Lapidus A, Prjibelski AD, Pyshkin A, Sirotkin A, Sirotkin Y, Stepanauskas R, Clingenpeel SR, Woyke T, McLean JS, Lasken R, Tesler G, Alekseyev MA, Pevzner PA. 2013. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol 20: 714-737. http://dx.doi.org/10.1089/cmb.2013.0084.
38. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068-2069. http://dx.doi.org/10.1093/bioinformat ics/btu153.
39. Witney AA, Marsden GL, Holden MT, Stabler RA, Husain SE, Vass JK, Butcher PD, Hinds J, Lindsay JA. 2005. Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol 71:7504-7514. http://dx.doi.org/10.1128/AEM.71.11.7504-7514.2005.
40. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. http://dx.doi.org/10.1093/jac/dks261.
41. Thuong M, Arvaniti K, Ruimy R, de la Salmonière P, Scanvic-Hameg A, Lucet JC, Régnier B. 2003. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect 53:274-282. http://dx.doi.org/10.1053/jhin.2002.1370.
42. Breathnach AS, Cubbon MD, Karunaharan RN, Pope CF, Planche TD. 2012. Multidrug-resistant Pseudomonas aeruginosa outbreaks in two hospitals: association with contaminated hospital waste-water systems. J Hosp Infect 82:19-24. http://dx.doi.org/10.1016/j.jhin.2012.06.007.
43. Kwan T, Liu J, Dubow M, Gros P, Pelletier J. 2006. Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J Bacteriol 188:1184-1187. http://dx.doi.org/10.1128/JB.188.3.1184-1187.2006.
44. Peña C, Suarez C, Tubau F, Juan C, Moya B, Dominguez MA, Oliver A, Pujol M, Ariza J. 2009. Nosocomial outbreak of a non-cefepimesusceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 bettalactamase. J Clin Microbiol 47:2381-2387. http://dx.doi.org/10.1128/JCM.00094-09.
45. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891-897. http://dx.doi.org/10.1128/AAC.44.4.891-897.2000.
46. Pawluk A, Bondy-Denomy J, Cheung VH, Maxwell KL, Davidson AR. 2014. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-cas system of Pseudomonas aeruginosa. mBio 5(2):e00896-14.
47. Palmer KL, Gilmore MS. 2010. Multidrug-resistant enterococci lack CRISPR-cas. mBio 1(4):e00227-10.
48. Kos VN, Déraspe M, McLaughlin RE, Whiteaker JD, Roy PH, Alm RA, Corbeil J, Gardner H. 2015. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 59:427-436. http://dx.doi.org/10.1128/AAC.03954-14.